SOURCE: World Street Fundamentals

September 22, 2011 09:00 ET

Factors Moving Markets, Worldwide View - Equity Research on Columbia Laboratories Inc. and Accuray Incorporated

HONG KONG--(Marketwire - Sep 22, 2011) - Today, www.WorldStreetFundamentals.com released its industry report highlighting Columbia Laboratories Inc. (NASDAQ: CBRX) and Accuray Incorporated (NASDAQ: ARAY). Full fundamental and technical analysis is available at www.WorldStreetFundamentals.com/Reports.php?id=CBRX+ARAY.

Continued confidence in long-term U.S. debt is defying S&P's recent downgrade. Treasury yields continue at their lowest levels since January 1, 2011 as the market moved to "safe investments" weary of the storm clouds ahead. Winds can change however, as a last-minute move to save the U.S. from a historic default on its debt obligations. Attentions are now turned to the situation in Europe, with the health of the Euro in the balance; bankers are looking to prevent defaults on Italian and Spanish debt.

As a result of recent credit adjustments, opportunity is being marked for investors to take advantage of equities with high-margin and specialty products. Market-wise investors are carefully watching for value within equities boasting established pipelines and excellent growth prospects. As part of this process, the following companies have been introduced with initial research reports available online.

World Street Fundamentals has highlighted Columbia Laboratories Inc. for its current position within the healthcare industry. Columbia Laboratories, Inc. (Columbia) focuses on developing products that utilize its bioadhesive drug delivery technologies to optimize drug delivery in a controlled, sustained manner. It focuses on funding new development projects through proof of concept, then partner for later-stage clinical development and commercialization. The entire report on Columbia Laboratories Inc. (NASDAQ: CBRX) is available here: www.WorldStreetFundamentals.com/Report.php?id=CBRX.

World Street has featured Accuray Incorporated for its development within the healthcare industry. Accuray Incorporated has developed a robotic radiosurgery system, CyberKnife Robotic Radiosurgery System, designed to treat solid tumors anywhere in the body as an alternative to traditional surgery. Its CyberKnife system represents the radiosurgery systems, combining continuous image-guidance technology with a compact linear accelerator (linac). The entire report on Accuray Incorporated (NASDAQ: ARAY) is available here: www.WorldStreetFundamentals.com/Report.php?id=ARAY.

About World Street
World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets.

Contact Information